Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreichs Ataxia
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting…
Platinum Industries Ltd. reports 64.7% revenue growth, exceeding INR 2 billion for H1 FY25; achieved INR 100 crore in revenue for both Q1 and Q2 FY25, with 63.6% YoY growth in Q2.
MUMBAI, India, Nov. 18, 2024 /PRNewswire/ -- Platinum Industries Ltd., a leading…
